The Paragard IUD litigation has become one of the most closely watched mass torts in the United States, with thousands of women alleging serious injuries caused by the popular copper intrauterine device. As of July 2025, the Paragard IUD litigation continues to evolve, with new lawsuits, ongoing multidistrict litigation (MDL) proceedings, and important updates shaping the legal landscape. This comprehensive guide from LitPRO explores the background of the Paragard IUD, the core allegations, recent legal developments, and best practices for law firms navigating Paragard IUD litigation—including the critical role of healthcare lien resolution.
What Is the Paragard IUD?
The Paragard IUD is a non-hormonal, T-shaped birth control device made of flexible plastic and copper, designed to prevent pregnancy for up to 10 years. Approved by the FDA in 1984, Paragard quickly became a popular long-term contraceptive option for women seeking hormone-free birth control. Unlike hormonal IUDs, Paragard relies on copper to create an environment in the uterus that is toxic to sperm.
Key Features
- Non-hormonal: Utilizes copper instead of synthetic hormones.
- Long-lasting: Approved for up to 10 years of use.
- Reversible: Can be removed at any time, theoretically restoring fertility immediately.
Why Is There Paragard IUD Litigation?
Thousands of women have filed lawsuits against Teva Pharmaceuticals (the original manufacturer) and CooperSurgical (the current owner), alleging that the Paragard IUD is prone to breaking during removal. Plaintiffs claim that the device’s arms can fracture inside the uterus, leading to severe complications such as:
- Uterine perforation
- Organ damage
- Infection
- Infertility
- The need for additional surgeries
Core Allegations in Paragard IUD Lawsuits
- Defective Design: Plaintiffs allege that the Paragard IUD’s design makes it unreasonably likely to break during removal.
- Failure to Warn: Lawsuits claim that manufacturers failed to adequately warn patients and healthcare providers about the risk of breakage and related complications.
- Negligence: Plaintiffs argue that Teva and CooperSurgical did not conduct sufficient safety testing or issue proper recalls despite reports of device failures.
Recent Updates in the Paragard IUD Litigation (2025)
Growth of the Paragard MDL
The Paragard IUD litigation is consolidated in MDL No. 2974 in the U.S. District Court for the Northern District of Georgia, overseen by Judge Leigh Martin May. As of July 2025, the MDL includes over 2,300 active cases, with more being filed monthly as awareness of the litigation spreads.
Key 2025 Developments
- Bellwether Case Selection: The court has chosen a set of bellwether cases for early trials, focusing on typical scenarios like device breakage during removal and resulting surgical interventions. These trials are expected to influence future settlement negotiations.
- Daubert Hearings: In early 2025, the court conducted Daubert hearings to assess the admissibility of expert testimony on Paragard IUD design and breakage risks. Most plaintiff experts were permitted to testify, strengthening the plaintiffs’ position at trial.
- Discovery and Motions: Discovery remains active, with both sides exchanging extensive documentation and depositions. Notably, plaintiffs won a key dispute when the court ordered the reopening of a corporate deposition after defendants improperly blocked questions about a 2023 internal audit. The judge made clear that only true legal communications are privileged and warned defendants against further obstruction, threatening sanctions for noncompliance. Discovery also continues to include new case filings, such as a recent lawsuit from a Delaware woman who required surgery after device breakage—cases involving surgical interventions and loss of fertility are anticipated to command higher settlement values.
- Settlement Talks: Mediation efforts are ongoing, but no global settlement has been reached. Many experts believe that the results of the initial bellwether trials will be pivotal in shaping broader settlement discussions.
FDA and Regulatory Updates
The FDA has not issued a recall of the Paragard IUD, but it has updated its adverse event database to reflect reports of device breakage and related complications. The agency continues to monitor the situation, and regulatory scrutiny remains high.
Injuries and Damages Alleged in Paragard IUD Lawsuits
Plaintiffs in the Paragard IUD litigation allege a range of injuries and damages, including:
- Physical Injuries: Uterine perforation, organ damage, pelvic pain, infection, and infertility.
- Surgical Interventions: Many women required additional procedures, including hysteroscopy, laparoscopy, or even hysterectomy, to retrieve broken device fragments.
- Emotional Distress: Plaintiffs report anxiety, depression, and trauma associated with unexpected surgeries and fertility concerns.
- Economic Losses: Medical expenses, lost wages, and future care costs.
Legal Theories and Challenges in Paragard IUD Litigation
Defective Design and Manufacturing
Plaintiffs argue that the Paragard IUD’s plastic arms are too brittle, making them prone to breakage during removal. Expert witnesses have pointed to material fatigue and design flaws that increase the risk of fracture.
Failure to Warn
Central to many lawsuits is the claim that manufacturers did not provide adequate warnings about the risk of breakage. Plaintiffs allege that package inserts and marketing materials downplayed or omitted this risk, leaving patients and doctors unprepared.
Preemption and Defenses
Defendants argue that the Paragard IUD was approved by the FDA and that federal law preempts certain state law claims. They also contend that breakage is a known risk with all IUDs and that proper removal techniques can mitigate the danger.
What Law Firms Should Know: Best Practices for Paragard IUD Litigation
1. Early Case Assessment
- Obtain complete medical records documenting Paragard IUD placement, removal, and any complications.
- Screen for device breakage and surgical interventions, as these cases tend to have higher settlement values.
2. Mastering Discovery and Expert Testimony
- Retain experts in gynecology, medical device engineering, and materials science to support defect and causation claims.
- Prepare for Daubert challenges by ensuring expert methodologies are robust and well-documented.
3. Navigating Settlement and Lien Resolution
- Understand the potential for Medicare, Medicaid, and private insurer liens on settlements.
- Work with lien resolution specialists to maximize client net recovery and ensure compliance.
4. Client Communication and Education
- Keep clients informed about the status of the litigation, bellwether trial schedules, and potential timelines for resolution.
- Educate clients about the importance of medical documentation and the role of healthcare liens in final settlement amounts.
The Role of Healthcare Lien Resolution in Paragard IUD Litigation
Healthcare lien resolution is a critical component of mass tort settlements, including Paragard IUD cases. Government programs (like Medicare and Medicaid), private insurers, and hospitals may assert reimbursement rights against settlements for medical care related to device injuries.
Why It Matters:
- Unresolved liens can delay settlement disbursement and reduce client recoveries.
- Failure to comply with lien resolution obligations can expose law firms to penalties and malpractice risk.
How LitPRO Helps:
- Early Identification: We proactively identify all potential healthcare liens.
- Negotiation: Our experts challenge unrelated or excessive charges and negotiate reductions where possible.
- Compliance: We ensure all reporting and payment obligations are met, protecting your firm and your clients.
The Paragard IUD litigation is a rapidly evolving mass tort with significant implications for women’s health, medical device regulation, and the legal landscape. As bellwether trials approach and more cases are filed, law firms must stay informed about legal developments, regulatory updates, and best practices for case management—including the often-overlooked but critical step of healthcare lien resolution.
How LitPRO Can Help with the Paragard IUD Litigation
Are you representing clients in the Paragard IUD litigation? Don’t let the complexities of healthcare lien resolution undermine your settlements or delay your clients’ compensation. Contact LitPRO today to discover how our expert lien resolution services can streamline your workflow, maximize client recoveries, and ensure full compliance with all regulatory requirements. Let LitPRO handle the intricacies of Paragard IUD lien resolution—so you can focus on delivering justice for your clients.
